Related Experiment Video
Updated: Mar 24, 2026

Indirect Immunofluorescence on Frozen Sections of Mouse Mammary Gland
Published on: December 1, 2015
CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation
Grace Ramena1, Yufang Yin2, Yang Yu1
1Dept of Medical Microbiology, Immunology, and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois, 62794, United States of America.
Abstract:
CLCA2 is a p53-, p63-inducible transmembrane protein that is frequently downregulated in breast cancer. It is induced during differentiation of human mammary epithelial cells, and its knockdown causes epithelial-to-mesenchymal transition (EMT). To determine how CLCA2 promotes epithelial differentiation, we searched for interactors using membrane dihybrid screening. We discovered a strong interaction with the cell junctional protein EVA1 (Epithelial V-like Antigen 1) and confirmed it by co-immunoprecipitation. Like CLCA2, EVA1 is a type I transmembrane protein that is regulated by p53 and p63. It is thought to mediate homophilic cell-cell adhesion in diverse epithelial tissues. We found that EVA1 is frequently downregulated in breast tumors and breast cancer cell lines, especially those of mesenchymal phenotype. Moreover, knockdown of EVA1 in immortalized human mammary epithelial cells (HMEC) caused EMT, implying that EVA1 is essential for epithelial differentiation. Both EVA1 and CLCA2 co-localized with E-cadherin at cell-cell junctions. The interacting domains were delimited by deletion analysis, revealing the site of interaction to be the transmembrane segment (TMS). The primary sequence of the CLCA2 TMS was found to be conserved in CLCA2 orthologs throughout mammals, suggesting that its interaction with EVA1 co-evolved with the mammary gland. A screen for other junctional interactors revealed that CLCA2 was involved in two different complexes, one with EVA1 and ZO-1, the other with beta catenin. Overexpression of CLCA2 caused downregulation of beta catenin and beta catenin-activated genes. Thus, CLCA2 links a junctional adhesion molecule to cytosolic signaling proteins that modulate proliferation and differentiation. These results may explain how attenuation of CLCA2 causes EMT and why CLCA2 and EVA1 are frequently downregulated in metastatic breast cancer cell lines.
Insights
Chloride channel CLCA2 and Epithelial V-like Antigen 1 (EVA1) are crucial for mammary epithelial differentiation. Their downregulation in breast cancer promotes tumor progression and metastasis.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Chloride channel CLCA2 is a transmembrane protein downregulated in breast cancer, and its loss induces epithelial-to-mesenchymal transition (EMT).
- Epithelial V-like Antigen 1 (EVA1) is a cell junction protein also regulated by p53/p63 and implicated in epithelial differentiation.
- Both CLCA2 and EVA1 are frequently downregulated in breast tumors, particularly in those with mesenchymal characteristics.
Purpose of the Study:
- To investigate the molecular mechanisms by which CLCA2 promotes epithelial differentiation.
- To identify CLCA2 interacting partners involved in maintaining epithelial characteristics.
Main Methods:
- Membrane yeast dihybrid screening to identify CLCA2 interactors.
- Co-immunoprecipitation to confirm protein-protein interactions.
- Deletion analysis to map interaction domains.
- Knockdown and overexpression studies in human mammary epithelial cells (HMECs).
Main Results:
- CLCA2 strongly interacts with the cell junction protein EVA1 via their transmembrane segments.
- EVA1 knockdown in HMECs induces EMT, highlighting its essential role in epithelial differentiation.
- CLCA2 and EVA1 co-localize with E-cadherin at cell-cell junctions.
- CLCA2 also interacts with ZO-1 and beta-catenin, and its overexpression downregulates beta-catenin signaling.
Conclusions:
- CLCA2 and EVA1 are critical for maintaining mammary epithelial cell adhesion and differentiation.
- The interaction between CLCA2 and EVA1, conserved across mammals, likely co-evolved with the mammary gland.
- CLCA2's role in linking cell adhesion to beta-catenin signaling explains its tumor-suppressive function and downregulation in metastatic breast cancer.
Related Concept Videos
Overview of Cell-Matrix Interactions
Laminins are the Adhesive Proteins of Basal Lamina
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Intracellular Signaling Affects Focal Adhesions
Some...
Anchoring Junctions
Adherens Junctions
Adherens Junctions are Dynamic

